VYNOVLI
LIVE

Serial Number

79199751

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 17, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VYNOVLI Trademark

Serial Number: 79199751 • Registration: 5215876

VYNOVLI is a trademark filed by NOVARTIS AG on November 17, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 17, 2016

Registration Date

June 6, 2017

Published for Opposition

March 21, 2017

Cancellation Date

December 22, 2023

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; ] pharmaceutical preparations for use in ophthalmology [ ; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Nov 1, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 4, 2024 INTS
INVALIDATION PROCESSED
Sep 4, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 23, 2024 INTR
CANCELLED SECTION 71
Dec 22, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 6, 2022 REM3
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 30, 2018 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 31, 2018 INPS
INVALIDATION PROCESSED
Oct 31, 2018 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 20, 2018 INPR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 27, 2018 LIMN
AMENDMENT UNDER SECTION 7 - PROCESSED
Feb 20, 2018 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 20, 2018 APRE
NOTIFICATION PROCESSED BY IB
Jul 28, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 7, 2017 FICS
FINAL DISPOSITION PROCESSED
Jul 7, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 6, 2017 GPAR
TEAS SECTION 7 REQUEST RECEIVED
Jul 5, 2017 ES7R
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 1, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2017 REAP
LIMITATION OF GOODS RECEIVED FROM IB
Jun 30, 2017 LIMG
REGISTERED-PRINCIPAL REGISTER
Jun 6, 2017 R.PR
PUBLISHED FOR OPPOSITION
Mar 21, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Mar 17, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 1, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 1, 2017 OP2R
NOTICE OF PUBLICATION
Mar 1, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2017 CNSA
ASSIGNED TO EXAMINER
Feb 8, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 21, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 13, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 5, 2017 REPR